Medical News
University News
Medical Publications
Resources
Medical News Releases > Faculty Experts at Washington University in St. Louis >

Jeffrey Moley

Director, Translational and Clinical Investigation, Siteman Cancer Center

Expertise: Thyroid cancer, endocrine surgery, surgical oncology, musculoskeletal oncology, melanoma

Bio: Moley is chief of endocrine and oncologic surgery at the School of Medicine and associate chief of surgery at the St. Louis Veteran's Administration Hospital. He is a world authority on endocrine surgery and endocrine cancers. Moley is especially known for his work on a hereditary cancer known as multiple endocrine neoplasia type 2, or MEN-2, which affects the thyroid and adrenal glands. He also conducts basic research studies on those tumors and led research that developed the only genetic test for the mutation that causes the disease.

Education:
  • M.D. in Medicine at Columbia University


News Stories & Tip Sheets:

Showing 1 Stories.
Tackling tumors

Thyroid cancer trial will test promising new drug called 17AAG

Aug. 3, 2005 -- A promising new anti-cancer drug will be tested against several forms of thyroid cancer in a newly opened clinical trial at the Siteman Cancer Center.



Showing 1 Stories.

Washington University in St. LouisSchool of Medicine

Affiliated with Barnes-Jewish Hospital and St. Louis Children's Hospital, members of BJC HealthCare.

Please contact us and let us know how we can assist you.
Technical problems with this Web site? Email questions or comments.
Please review the WUSTL News & Information copyright/privacy policy.













Related Information
Media Assistance:

Gwen Ericson
Assistant Director of Research Communications
ericsong@wustl.edu

(314) 286-0141
Contact Information

Related Links:
Moley's Siteman Web page

Related Groups:

Schools:
School of Medicine

Departments:
Cancer

Programs:
Endocrinology, Metabolism & Lipids

- View All Groups

Related Topics:
Cancer

- View All Topics

Revised:

Thursday, Aug. 11, 2005


  Print ready page